Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medullary thyroid carcinoma.

Sophie Leboulleux1, Eric Baudin, Jean-Paul Travagli

  • 1Institut Gustave Roussy, Villejuif, France.

Clinical Endocrinology
|September 10, 2004
PubMed
Summary

Medullary thyroid carcinoma (MTC) is a rare cancer originating from C cells. Early detection through genetic analysis and screening for related conditions improves outcomes, but treatments for distant metastases are lacking.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility.

Endocrine-related cancer·2026
Same author

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Communications medicine·2026
Same author

Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

BMC cancer·2026
Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026
Same author

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Neuroendocrine tumors and pregnancy: the French PregNET study.

European journal of endocrinology·2026

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Medullary thyroid carcinoma (MTC) originates from C cells, accounting for 5-10% of thyroid cancers.
  • Hereditary MTC occurs in approximately 25% of cases, necessitating genetic analysis.
  • MTC diagnosis has implications for evaluating disease extent and screening for phaeochromocytoma and hyperparathyroidism.

Purpose of the Study:

  • To review pathological characteristics, tumor markers, and genetic abnormalities in MTC.
  • To describe diagnostic and therapeutic modalities for both clinical and preclinical MTC.
  • To highlight advances in MTC management and identify unmet needs.

Main Methods:

  • Review of pathological features of MTC.
  • Analysis of tumor markers for MTC detection.
  • Genetic analysis of the RET proto-oncogene for hereditary MTC.
  • Description of diagnostic and therapeutic strategies.

Main Results:

  • Advances in genetics, initial treatment, and pheochromocytoma management have improved long-term outcomes.
  • Early detection through familial screening identifies preclinical disease.
  • No effective treatments currently exist for distant MTC metastases.

Conclusions:

  • Improved understanding of MTC genetics and comprehensive management strategies enhance patient outcomes.
  • There is an urgent need for novel therapeutic approaches to address distant MTC metastases.
  • Continued research into MTC pathogenesis and treatment is crucial.

Related Experiment Videos